Services: Diversified Services

Genetic Technologies Ltd (GENE: NASDAQ)

$3.18 -0.01 | -0.31%
07/31/15 - 10:12 AM ET
Company Cash Flow
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Cash Flow From Operating Activities
Net Income (Loss) -9.54M -8.68M -5.42M 963.32K
Operating Gains/Losses 182.50K 405.49K -5.28M 305.45K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -737.12K 155.27K 182.69K 85.81K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 194.27K -178.00K -15.17K 0.00
(Decrease) Increase In Payables 69.34K 435.89K -214.30K -86.19K
(Decrease) Increase In Other Current Liabilities -221.81K 14.83K 0.00 -33.02K
(Increase) Decrease In Other Working Capital -748.99K 50.23K 194.72K 44.67K
Other Non-Cash Items 156.17K 319.28K 2.18M 558.81K
Net Cash From Continuing Operations -10.34M -6.97M -7.86M 2.39M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -10.34M -6.97M -7.86M 2.39M
Sale of Property, Plant & Equipment 0.00 1.11K 32.21K 154.66K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -45.11K -49.74K -78.15K -149.28K
Acquisitions 0.00 -117.14K 10.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -172.34K 0.00 549.97K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 218.78K -165.77K 504.04K 5.38K
Issuance of Debt 5.25M 0.00 1.02M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 6.59M 446.78K 11.16M 0.00
Repayment of Long-Term Debt 0.00 -16.47K -1.08M -336.41K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -619.97K -23.94K 0.00 0.00
Net Cash From Financing Activities 11.23M 406.38K 11.11M -336.41K
Effect of Exchange Rate Changes -55.04K 72.87K 129.54K -133.80K
Net Change in Cash & Cash Equivalents 1.04M -6.66M 3.89M 1.92M

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter